Dyne Therapeutics jumps amid report of takeover interest

Dyne Therapeutics jumps amid report of takeover interest
2.9BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US26818M1080
CUSIP
26817G300
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.19
Book Value
4.97
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.62
Wall Street Target Price
34.33
EPS Estimate Current Year
-3.89
EPS Estimate Next Year
-3.61
EPS Estimate Current Quarter
-0.8819
EPS Estimate Next Quarter
-0.9069
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-617,868,032
Profit Margin
0.00%
Return On Assets TTM
-36.88%
Return On Equity TTM
-74.56%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-3.62
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
3.12
Enterprise Value Revenue
0
Enterprise Value EBITDA
-8
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%